PhD, Group Leader Cellular Pharmacology
Reaction Biology Europe GmbH, Germany
Dr. Daniel Feger is a biochemist by training. In his PhD thesis at the tumor biology center in Freiburg, Germany, he worked in the field of tumor angiogenesis. After his PhD he started working in the department Drug Discovery and Service Business at Reaction Biology (former ProQinase GmbH). Since 2013, he is a group leader in the cellular pharmacology department and responsible for the project management of cell-based customer projects. He has broad expertise in cell biology and assay development and has extensive experience in preclinical drug development in the field of oncology.